Scarica l'app Stockscreener
22.52
0.49%
-0.11
Dopo l'orario di chiusura:
21.80
-0.72
-3.20%
Elanco Animal Health Inc Borsa (ELAN) Ultime notizie
Elanco Animal Health Inc (ELAT) Fundamental Analysis - Meyka
ELAN SEC FilingsElanco Animal Health 10-K, 10-Q, 8-K Forms - Stock Titan
Elanco (ELAN) Gains USDA Approval for Befrena Injections - GuruFocus
Elanco (ELAN) Gains USDA Approval for New Canine Dermatology Tre - GuruFocus
Elanco gains approval of Befrena for canine dermatitis - Seeking Alpha
Elanco receives USDA approval for canine dermatitis treatment By Investing.com - Investing.com Canada
Elanco Receives USDA Approval for Befrena™ (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis - PR Newswire
Voya Investment Management LLC Sells 2,335,093 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco (ELAN) CEO Jeffrey Simmons reports new deferred stock units - Stock Titan
Elanco (ELAN) EVP reports new deferred stock units award - Stock Titan
Targets Report: Will Elanco Animal Health Incorporated 5EA stock outperform value peers2025 EndofYear Setup & Free Low Drawdown Momentum Trade Ideas - moha.gov.vn
Yousif Capital Management LLC Boosts Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
EBITDA per share of Elanco Animal Health, Inc. – FWB:5EA - TradingView — Track All Markets
Elanco Animal Health Incorporated (NYSE:ELAN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Elanco Animal Health Incorporated $ELAN Shares Sold by Harbor Capital Advisors Inc. - MarketBeat
Exchange Traded Concepts LLC Acquires Shares of 262,281 Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Earnings Notes - Trefis
Elanco Animal Health Inc (ELAN) director gifts 60,000 shares - Stock Titan
Elanco Animal Health working to combat New World screwwrorm - norfolkneradio.com
Oasis of Zen - Exhibitor Online
Middle East And Africa Animal Healthcare Market Forecast - openPR.com
Jim Cramer on Elanco Animal Health: "They Are Doing Everything Right" - Finviz
How Conditional FDA Approval of Credelio Quattro-CA1 Could Impact Elanco Animal Health (ELAN) Investors - Yahoo Finance
Jim Cramer on Elanco Animal Health: “They Are Doing Everything Right” - Yahoo Finance
Douglas Lane & Associates LLC Cuts Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health (FRA:5EA) EV-to-OCF : 22.34 (As of Dec. 21, 2025) - GuruFocus
Does Elanco’s 85% 2025 Rally Match Its Long Term Valuation Prospects? - Yahoo Finance
Veterinary Medicine Market Size to Hit USD 98.51 Billion by 2033, Growing at a CAGR of 8.11%SNS Insider - GlobeNewswire
Wall Street Zen Downgrades Elanco Animal Health (NYSE:ELAN) to Buy - MarketBeat
Is Elanco Animal Health Incorporated stock dividend yield sustainableJuly 2025 Levels & Risk Controlled Swing Alerts - ulpravda.ru
Is Elanco Animal Health Incorporated stock a contrarian opportunityTrade Ideas & Weekly High Potential Stock Alerts - Улправда
Stifel maintains Buy rating on Elanco Animal Health stock with $27 price target - Investing.com Canada
Will Elanco Animal Health Incorporated stock benefit from automationEarnings Summary Report & AI Enhanced Trading Signals - Bölüm Sonu Canavarı
Elanco CEO Bites Off More Shares of Fast-Rising Stock - Barron's
Is Elanco Animal Health Incorporated (5EA) stock positioned for digital growth eraTrade Risk Assessment & Target Return Focused Picks - DonanımHaber
Companion Animal Vaccine Market is Going to Boom: New Report - openPR.com
Hedge Fund and Insider Trading News: Bill Ackman, Warren Buffett, Steve Cohen, Citadel Investment Group, Elliott Management, Altai Capital, Elanco Animal Health Inc (ELAN), NVIDIA Corp (NVDA), and More - Insider Monkey
Elanco focused on production animals - norfolkneradio.com
Elanco Animal Health (NYSE:ELAN) Price Target Raised to $22.00 - MarketBeat
FDA conditionally approves Elanco’s treatment for screwworm in dogs By Investing.com - Investing.com Australia
FDA conditionally approves Elanco’s treatment for screwworm in dogs - Investing.com India
Elanco's Credelio Quattro™-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs - PR Newswire
Jim Cramer Praises Elanco Animal Health: 'They've Turned That Company Around' - Benzinga
Elanco Animal Health (ELAN) Receives a Buy from Barclays - The Globe and Mail
Elanco (ELAN): Valuation Check After Insider Buying Spree and New Restructuring Plan - Yahoo Finance
Elanco (ELAN) Stock Is Up, What You Need To Know - The Globe and Mail
Elanco Animal Health Director Purchases 10,000 Shares - TradingView — Track All Markets
[Form 4] Elanco Animal Health Inc Insider Trading Activity - Stock Titan
Elanco Animal Health Inc (ELAN) EVP reports 66.4453 deferred stock units - Stock Titan
Elanco Animal Health Inc. (ELAN) CEO reports new deferred stock units award - Stock Titan
Elanco Animal Health (NYSE:ELAN) Shares Little Changed After Results - Kalkine Media
Elanco Animal Health (NYSE:ELAN) Shares Gap Up Following Insider Buying Activity - MarketBeat
Smart Money Move: Jeffrey N Simmons Grabs $478K Worth Of Elanco Animal Health Stock - Benzinga
Robert M VanHimbergen Takes a Bullish Stance: Acquires $150K In Elanco Animal Health Stock - Benzinga
Are Medical Stocks Lagging Elanco Animal Health (ELAN) This Year? - Yahoo Finance
Elanco Animal Health (ELAN) Gets a Buy from Bank of America Securities - The Globe and Mail
VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm - GlobeNewswire Inc.
Elanco to Layoff 300 Employees, Shift Another 300 to Other Locations - 101.5 WKKG
Insider Purchases Boost Elanco (ELAN) Stock - GuruFocus
Elanco Animal Health EVP Modi buys $95,984 in stock By Investing.com - Investing.com South Africa
Elanco Animal Health EVP Modi buys $95,984 in stock - Investing.com
Insider Buying: Elanco Animal Health (NYSE:ELAN) CFO Purchases 6,950 Shares of Stock - MarketBeat
1.28%
0.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):